Michael O. Harris‐Love

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

Chester V. Oddis, Ann M. Reed, Rohit Aggarwal et al. · Arthritis & Rheumatism · 2012 · 691 citations

Medicine, Immunology, Pharmacotherapy +14

Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis

Rohit Aggarwal, Andriy I. Bandos, Ann M. Reed et al. · Arthritis & Rheumatology · 2013 · 282 citations · Full text

Medicine, Immunology, Internal Medicine +14

Clinical features of spinal and bulbar muscular atrophy

Lindsay Fernández‐Rhodes, Brandi K. Freeman, Sungyoung Auh et al. · Brain · 2009 · 206 citations · Full text

Medicine, Endocrinology, Neurology +17

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

Marinos C. Dalakas, Goran Rakočević, Jan Schmidt et al. · Brain · 2009 · 204 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Defining Clinical Improvement in Adult and Juvenile Myositis.

Lisa G. Rider, Edward H. Giannini, Michael O. Harris‐Love et al. · PubMed · 2003 · 183 citations

Medicine, Neurology, Pediatrics +13